FdaApplication
ANDA 076089
Identifiers
- fda_app_no: ANDA076089
Properties
| Property | Value |
|---|---|
| applicant_name | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA |
| application_type | ANDA |
| approval_date | 2004-06-09 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CIPROFLOXACIN | CIPROFLOXACIN | 100MG | TABLET;ORAL |
| CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | EQ 250MG BASE | TABLET;ORAL |
| CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | EQ 500MG BASE | TABLET;ORAL |
| CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | EQ 750MG BASE | TABLET;ORAL |
4 products